These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 31092081)

  • 1. Chronic obstructive pulmonary disease and comorbidities' influence on mortality in non-small cell lung cancer patients.
    Media AS; Persson M; Tajhizi N; Weinreich UM
    Acta Oncol; 2019 Aug; 58(8):1102-1106. PubMed ID: 31092081
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of chronic obstructive pulmonary disease on the mortality of patients with non-small-cell lung cancer.
    Lee SJ; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Yoo CG; Han SK; Kim YW
    J Thorac Oncol; 2014 Jun; 9(6):812-7. PubMed ID: 24807154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of different comorbidities on survival of non-small cells lung cancer patients.
    Iachina M; Jakobsen E; Møller H; Lüchtenborg M; Mellemgaard A; Krasnik M; Green A
    Lung; 2015 Apr; 193(2):291-7. PubMed ID: 25516286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between chronic obstructive pulmonary disease and non-small cell lung cancer in the elderly.
    Wang P; Zhu M; Zhang D; Guo XG; Zhao S; Zhang XL; Wang DL; Liu CT
    Cancer Med; 2019 Aug; 8(9):4124-4134. PubMed ID: 31184445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection.
    Zhai R; Yu X; Shafer A; Wain JC; Christiani DC
    Chest; 2014 Feb; 145(2):346-353. PubMed ID: 24008835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients.
    Lim JU; Yeo CD; Rhee CK; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Yoon HK; Lee SH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():929-938. PubMed ID: 31118602
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of psychiatric disorders on the course of lung cancer, chronic obstructive pulmonary disease and tuberculosis.
    Sikjær MG; Løkke A; Hilberg O
    Respir Med; 2018 Feb; 135():35-41. PubMed ID: 29414451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of survival of chronic obstructive pulmonary disease patients with or without a localized non-small cell lung cancer.
    Jeppesen SS; Hansen NG; Schytte T; Nielsen M; Hansen O
    Lung Cancer; 2016 Oct; 100():90-95. PubMed ID: 27597286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment for lung cancer with COPD based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD).
    Iwasaki A; Shirakusa T; Enatsu S; Maekawa S; Yoshida Y; Yoshinaga Y
    Thorac Cardiovasc Surg; 2005 Jun; 53(3):162-7. PubMed ID: 15926096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidities in lung cancer: prevalence, severity and links with socioeconomic status and treatment.
    Grose D; Morrison DS; Devereux G; Jones R; Sharma D; Selby C; Docherty K; McIntosh D; Louden G; Nicolson M; McMillan DC; Milroy R;
    Postgrad Med J; 2014 Jun; 90(1064):305-10. PubMed ID: 24676985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients.
    Lim JU; Yeo CD; Rhee CK; Kim YH; Park CK; Kim JS; Kim JW; Kim SJ; Yoon HK; Lee SH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2139-2146. PubMed ID: 30034229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma.
    Huang JY; Jian ZH; Ndi Nfor O; Jhang KM; Ku WY; Ko PC; Jan SR; Ho CC; Lung CC; Pan HH; Liang YC; Liaw YP
    PLoS One; 2015; 10(7):e0133367. PubMed ID: 26196516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():893-903. PubMed ID: 31118599
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of comorbidities in COPD patients by disease severity in a German population.
    Greulich T; Weist BJD; Koczulla AR; Janciauskiene S; Klemmer A; Lux W; Alter P; Vogelmeier CF
    Respir Med; 2017 Nov; 132():132-138. PubMed ID: 29229085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO study.
    López Varela MV; Montes de Oca M; Halbert R; Muiño A; Tálamo C; Pérez-Padilla R; Jardim JR; Valdivia G; Pertuzé J; Menezes AM;
    Arch Bronconeumol; 2013 Nov; 49(11):468-74. PubMed ID: 23856439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of emphysema and airway obstruction in prognosis of lung cancer.
    Gullón JA; Suárez I; Medina A; Rubinos G; Fernández R; González I
    Lung Cancer; 2011 Feb; 71(2):182-5. PubMed ID: 20554345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of Chronic Obstructive Pulmonary Disease on Risk of Recurrence in Patients with Resected Non-small Cell Lung Cancer].
    Qiang G; Yu Q; Liang C; Song Z; Shi B; Guo Y; Liu D
    Zhongguo Fei Ai Za Zhi; 2018 Mar; 21(3):215-220. PubMed ID: 29587946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of multiple comorbidities on mortality in chronic obstructive pulmonary disease among Korean population: a nationwide cohort study.
    Kim Y; Kim YJ; Cho WK
    BMC Pulm Med; 2021 Feb; 21(1):56. PubMed ID: 33573635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study.
    Laforest L; Roche N; Devouassoux G; Belhassen M; Chouaid C; Ginoux M; Van Ganse E
    Respir Med; 2016 Aug; 117():33-9. PubMed ID: 27492511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of medical comorbidities on the presentation and outcomes of stage I-III non-small-cell lung cancer.
    Ahn DH; Mehta N; Yorio JT; Xie Y; Yan J; Gerber DE
    Clin Lung Cancer; 2013 Nov; 14(6):644-50. PubMed ID: 23886797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.